
Sign up to save your podcasts
Or


My guest this week is James Lanthier, CEO of Mindset Pharma of Toronto, Canada, a company that is seeking to develop novel psychedelic analogues to existing psychedelics such as psilocybin, DMT, and 5-MeO-DMT for more targeted delivery, efficacy, and therapeutic potential for use in the developing psychedelic healthcare field. You can find them online at www.mindsetpharma.com
By Martin W. Ball4.1
106106 ratings
My guest this week is James Lanthier, CEO of Mindset Pharma of Toronto, Canada, a company that is seeking to develop novel psychedelic analogues to existing psychedelics such as psilocybin, DMT, and 5-MeO-DMT for more targeted delivery, efficacy, and therapeutic potential for use in the developing psychedelic healthcare field. You can find them online at www.mindsetpharma.com

3,416 Listeners

329 Listeners

1,859 Listeners

1,276 Listeners

372 Listeners

309 Listeners

8,961 Listeners

1,630 Listeners

472 Listeners

276 Listeners

168 Listeners

29,235 Listeners

265 Listeners

9,951 Listeners

602 Listeners